LENZ Therapeutics (LENZ) Gains from Investment Securities: 2020-2024
Historic Gains from Investment Securities for Therapeutics (LENZ) over the last 5 years, with Dec 2024 value amounting to $1.4 million.
- Therapeutics' Gains from Investment Securities was N/A to $10,367 in Q3 2023 from the same period last year, while for Sep 2023 it was $339,422, marking a year-over-year change of. This contributed to the annual value of $1.4 million for FY2024, which is 624.74% up from last year.
- According to the latest figures from FY2024, Therapeutics' Gains from Investment Securities is $1.4 million, which was up 624.74% from $190,000 recorded in FY2023.
- In the past 5 years, Therapeutics' Gains from Investment Securities ranged from a high of $5.0 million in FY2021 and a low of $190,000 during FY2023.
- Over the past 3 years, Therapeutics' median Gains from Investment Securities value was $200,000 (recorded in 2022), while the average stood at $589,000.
- Per our database at Business Quant, Therapeutics' Gains from Investment Securities crashed by 96.00% in 2022 and then soared by 624.74% in 2024.
- Over the past 5 years, Therapeutics' Gains from Investment Securities (Yearly) stood at $2.8 million in 2020, then surged by 78.57% to $5.0 million in 2021, then crashed by 96.00% to $200,000 in 2022, then dropped by 5.00% to $190,000 in 2023, then skyrocketed by 624.74% to $1.4 million in 2024.